Nanoscope Therapeutics was recently singled out for its ground-breaking optogenetics drug at the OIS Retina Innovation Summit in New York, the latest achievement in the company’s quest to restore meaningful vision to the millions of us suffering from debilitating retinal diseases. Since announcing the remarkable results of its Phase 1/2a clinical trial for Retinitis Pigmentosa … Continue reading Nanoscope Wins Breakout Technology Award for Vision-Restoring Drug